Segall Bryant & Hamill’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-8,150
Closed -$2.47M 587
2023
Q2
$2.47M Hold
8,150
0.03% 412
2023
Q1
$2.15M Hold
8,150
0.02% 418
2022
Q4
$1.96M Hold
8,150
0.02% 419
2022
Q3
$1.5M Hold
8,150
0.02% 452
2022
Q2
$1.37M Hold
8,150
0.02% 466
2022
Q1
$2.04M Sell
8,150
-50
-0.6% -$12.6K 0.02% 442
2021
Q4
$2.11M Hold
8,200
0.02% 405
2021
Q3
$1.99M Buy
+8,200
New +$2M 0.02% 464
2015
Q1
Sell
-5,672
Closed -$416K 557
2014
Q4
$416K Sell
5,672
-300
-5% -$21.1K 0.01% 441
2014
Q3
$421K Buy
+5,972
New +$395K 0.01% 448

Other funds holding HCA

Segall Bryant & Hamill's HCA Position: Q3 2023 in Review

Segall Bryant & Hamill sold out of HCA Healthcare (HCA) in Q3 2023, closing a stake of 8,150 shares — an estimated $2.47M sold.

Segall Bryant & Hamill first reported a position in HCA in Q3 2014 and held it in 10 quarters. The position peaked at $2.47M in Q2 2023. 1,000 funds tracked by Wall St. Rank hold HCA as of Q3 2023.

  • Segall Bryant & Hamill reported no remaining HCA Healthcare position as of Q3 2023 after selling out during the quarter.
  • Segall Bryant & Hamill sold 8,150 HCA Healthcare shares in Q3 2023, an estimated $2.47M.
  • Segall Bryant & Hamill first reported a position in HCA Healthcare in Q3 2014 and held it in 10 quarters.
  • Segall Bryant & Hamill's HCA Healthcare position peaked at $2.47M in Q2 2023.
  • 1,000 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2023.

Based on Segall Bryant & Hamill's 13F filing for Q3 2023, filed 9 Nov 2023.